NCOA2 and prostate carcinoma: Furthermore, a recent study demonstrated that SRC-2 promotes lipogenesis and enhanced cell survival and metastasis in prostate cancer [27], suggesting a tissue-specific and context-dependent role for SRC-2 in tumorigenesis.